Stockscreener 앱 받기
1.59
7.56%
-0.13
시간 외 거래:
1.60
0.01
+0.63%
Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스
Research Analysts Set Expectations for PRQR Q2 Earnings - Defense World
ProQR (NASDAQ: PRQR) director details substantial share and long-dated option holdings - Stock Titan
ProQR (PRQR) CSO details sizeable option grants and share stake - Stock Titan
Director Maier details ProQR (PRQR) share option grants and vesting - Stock Titan
ProQR (PRQR) director Alison Lawton details multiple option grants - Stock Titan
ProQR (PRQR) CFO discloses 1,000,000-share option position in Form 3 - Stock Titan
Theresa Heggie (PRQR) details option and share holdings in Form 3 - Stock Titan
ProQR Therapeutics N.V. (PRQR) director files Form 3 for options - Stock Titan
ProQR (PRQR) CEO Daniel de Boer details long-dated option grants - Stock Titan
ProQR Therapeutics (PRQR) director reports five long-dated option grants - Stock Titan
ProQR Therapeutics (PRQR) director discloses share and option holdings - Stock Titan
Q2 Earnings Estimate for PRQR Issued By HC Wainwright - MarketBeat
Brokers Issue Forecasts for PRQR Q1 Earnings - MarketBeat
Aug Sentiment: Whats the RSI of ProQR Therapeutics NV stock2026 Highlights & Low Risk Profit Maximizing Plans - baoquankhu1.vn
ProQR Therapeutics N.V.Ordinary Shares (NQ: PRQR - The Chronicle-Journal
Recap Report: Is ProQR Therapeutics NV a strong candidate for buy and hold2026 Volume Leaders & AI Optimized Trade Strategies - baoquankhu1.vn
Breakout Zone: Is ProQR Therapeutics NV attractive for institutional investors2026 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
ProQR Therapeutics (NASDAQ:PRQR) Raised to Hold at Wall Street Zen - MarketBeat
ProQR Therapeutics NV earnings beat by €0.02, revenue topped estimates - Investing.com Nigeria
ProQR Therapeutics (NASDAQ:PRQR) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Citizens reiterates ProQR Therapeutics stock rating on RNA editing platform potential - Investing.com
ProQR Therapeutics Q4 Net Loss Of €8.9 Million Reinforces Profitability Concerns - Sahm
ProQR Therapeutics N.V. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PRQR SEC FilingsProqr Therapeuti 10-K, 10-Q, 8-K Forms - Stock Titan
ProQR Therapeutics (NASDAQ:PRQR) Coverage Initiated at Oppenheimer - MarketBeat
ProQR Therapeutics Q4 2025 Financial Results: Loss of $9.1MNews and Statistics - IndexBox
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
ProQR: Q4 Earnings Snapshot - marketscreener.com
ProQR Therapeutics NV reports results for the quarter ended December 31Earnings Summary - TradingView
ProQR Posts 2025 Results as Axiomer RNA Editing Pipeline Advances and Cash Runway Extends to Mid-2027 - TipRanks
ProQR (PRQR) Advances Clinical Trials Amid Reduced Cash Holdings - GuruFocus
ProQR Therapeutics (NASDAQ: PRQR) details 2025 loss, cash runway and RNA editing focus - Stock Titan
ProQR Announces Year End 2025 Operating and Financial Results - Weekly Voice
Biotech ProQR ends 2025 with €92.4M cash, eyes key trial readout in 2026 - Stock Titan
ProQR (Nasdaq: PRQR) widens 2025 loss as R&D spending rises - Stock Titan
ProQR: Fourth Quarter Financial Overview - Bitget
Analysts Set ProQR Therapeutics Price Target at $7.14 - National Today
ProQR Therapeutics NV expected to post a loss of 10 cents a shareEarnings Preview - TradingView
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Quarterly Risk: Can ProQR Therapeutics NV weather a recession2025 Big Picture & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Weekly Trades: Is ProQR Therapeutics NV backed by strong institutional buyingJuly 2025 Pullbacks & Verified Momentum Stock Alerts - baoquankhu1.vn
Highs Report: Is ProQR Therapeutics NV a strong candidate for buy and holdMarket Growth Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Portfolio Shifts: Can ProQR Therapeutics NV benefit from deglobalization2025 Market Sentiment & AI Forecasted Stock Moves - baoquankhu1.vn
Is ProQR Therapeutics NV backed by strong institutional buyingWeekly Trend Recap & Risk Controlled Daily Plans - baoquankhu1.vn
Retinitis Pigmentosa Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc - Barchart.com
ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference - 富途牛牛
Surprises Report: Is ProQR Therapeutics NV a potential multi baggerWeekly Market Summary & Expert Approved Trade Ideas - baoquankhu1.vn
PRQR Should I Buy - Intellectia AI
Retail Trends: Is ProQR Therapeutics NV a potential multi baggerJuly 2025 Momentum & Risk Managed Investment Signals - baoquankhu1.vn
Aberdeen Group plc Grows Position in ProQR Therapeutics N.V. $PRQR - Defense World
Can ProQR Therapeutics N.V. weather a recession2025 Fundamental Recap & Low Drawdown Momentum Ideas - mfd.ru
ProQR Therapeutics (PRQR) Leadership to Discuss Company Developm - GuruFocus
Aug Shorts: Is ProQR Therapeutics NV stock a buy or sellProfit Target & High Return Stock Watch Alerts - baoquankhu1.vn
How interest rate cuts could boost ProQR Therapeutics N.V. stockProfit Target & Real-Time Buy Signal Notifications - mfd.ru
What’s the RSI of ProQR Therapeutics N.V. stock2025 Big Picture & Community Verified Trade Alerts - mfd.ru
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 47.2% in January - MarketBeat
Can ProQR Therapeutics N.V. withstand a market correctionCPI Data & Community Verified Watchlist Alerts - mfd.ru
Is ProQR Therapeutics N.V. currently under institutional pressureChart Signals & Long-Term Growth Portfolio Plans - mfd.ru
PRQR PE Ratio & Valuation, Is PRQR Overvalued - Intellectia AI
Will ProQR Therapeutics N.V. stock recover after earningsPortfolio Gains Summary & Weekly High Conviction Trade Ideas - mfd.ru
A | Is ProQR Therapeutics N.V. stock showing strong momentumJuly 2025 Levels & Risk Controlled Swing Alerts - mfd.ru
1.20%
0.06%
자본화:
|
볼륨(24시간):